Trial Profile
A Randomized, Double-blind, Placebo-controlled, Dose-Escalation Study Evaluating the Safety, Tolerability, and Immunogenicity of an Oral Inactivated ETEC Vaccine (ETVAX) Alone and Together With dmLT Adjuvant in Descending Age Groups in Bangladesh
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 22 Nov 2021
Price :
$35
*
At a glance
- Drugs Traveller's diarrhoea vaccine (Primary)
- Indications Traveller's diarrhoea
- Focus Adverse reactions
- 09 Nov 2021 Results published in the Vaccine
- 22 Nov 2018 Results of phase I of the study (n=45) in healthy adults published in the Vaccine.
- 14 Nov 2017 Status changed from recruiting to completed.